News
It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has ...
1d
Zacks Investment Research on MSNInternational Growth Drives GMED Stock Amid Fierce CompetitionGlobus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging ...
1d
Interesting Engineering on MSNWas Earth’s evolution shaped by a dying star? A 2.5-million-year-old clue emergesOf the heavy metals spewed by dying stars, the astronomers were particularly interested in iron-60. That’s because iron-60 is ...
BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader ...
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...
Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.
In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...
SI-BONE, Inc. reported $48 million in sales and an operating loss of $4.5 million for the quarter ending December 31, 2024. The full year 2024 revenue, which was in line with Wall Street’s ...
The restructuring plan comes about six weeks after Teleflex announced it would split into two separate, public entities.
Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.
Mouse studies demonstrated that newly generated neurons connect with brain networks responsible for motor control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results